These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 22009549)

  • 1. A case of femoral diaphyseal fracture after long-term treatment with zoledronic acid.
    Ishizuna K; Ota D; Fukuuchi A; Teraoka M; Fujii A; Mori M; Nishi T
    Breast Cancer; 2015 Jan; 22(1):90-4. PubMed ID: 22009549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bisphosphonate-related atypical femoral fracture with bone metastasis of breast cancer: case report and review.
    Hayashi K; Aono M; Shintani K; Kazuki K
    Anticancer Res; 2014 Mar; 34(3):1245-9. PubMed ID: 24596367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spontaneous Bilateral Femoral Fractures After High-Dose Zoledronic Acid.
    Brin YS; Palmanovich E; Heler Z; Kish BJ; Nyska M; Bismuth H; Coughlin R; Zehavi T; Rotman P
    Orthopedics; 2015 Nov; 38(11):e1051-4. PubMed ID: 26558671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequential subtrochanteric femoral fracture after atypical diaphyseal fracture in a long-term bisphosphonate user: a case report.
    Park KT; Lee KB
    Acta Chir Orthop Traumatol Cech; 2015; 82(2):157-60. PubMed ID: 26317188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atypical femoral shaft fracture in a patient with non-metastatic prostate cancer on zoledronic acid therapy: effect of therapy or coincidence?
    Reddy SV; Gupta SK
    Singapore Med J; 2012 Mar; 53(3):e52-4. PubMed ID: 22434305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The first reported case of Atypical Femoral Fracture caused by daily ibandronate prescribed for bone metastases in breast cancer.
    Espey R; Grimes S; Heyburn G; Kealey WD
    BMJ Case Rep; 2017 May; 2017():. PubMed ID: 28487299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical femur fractures among breast cancer and multiple myeloma patients receiving intravenous bisphosphonate therapy.
    Chang ST; Tenforde AS; Grimsrud CD; O'Ryan FS; Gonzalez JR; Baer DM; Chandra M; Lo JC
    Bone; 2012 Sep; 51(3):524-7. PubMed ID: 22634175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subtrochanteric fracture in a patient receiving zoledronic acid therapy for metastatic breast cancer.
    Kishimoto Y; Iwase T; Koyama A; Masui T; Yoshida G; Matsuo H; Ishiguro N
    Nagoya J Med Sci; 2011 Aug; 73(3-4):211-5. PubMed ID: 21928703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bisphosphonates and fractures of the subtrochanteric or diaphyseal femur.
    Black DM; Kelly MP; Genant HK; Palermo L; Eastell R; Bucci-Rechtweg C; Cauley J; Leung PC; Boonen S; Santora A; de Papp A; Bauer DC; ;
    N Engl J Med; 2010 May; 362(19):1761-71. PubMed ID: 20335571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical fracture of the tibial diaphysis associated with bisphosphonate therapy: a case report.
    Bissonnette L; April PM; Dumais R; Boire G; Roux S
    Bone; 2013 Oct; 56(2):406-9. PubMed ID: 23871749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atraumatic bilateral femur fracture in long-term bisphosphonate use.
    Goddard MS; Reid KR; Johnston JC; Khanuja HS
    Orthopedics; 2009 Aug; 32(8):. PubMed ID: 19708622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel case of bisphosphonate-related osteonecrosis of the torus palatinus in a patient with metastatic breast cancer.
    Goldman ML; Denduluri N; Berman AW; Sausville R; Guadagnini JP; Kleiner DE; Brahim JS; Swain SM
    Oncology; 2006; 71(3-4):306-8. PubMed ID: 17657174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical efficacy and safety of zoledronic acid in prostate and breast cancer.
    Doggrell SA
    Expert Rev Anticancer Ther; 2009 Sep; 9(9):1211-8. PubMed ID: 19761424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zoledronic acid-associated symmetrical drug-related intertriginous and flexural exanthema (SDRIFE): report of baboon syndrome in a woman with recurrent metastatic breast cancer after receiving zoledronic acid.
    Cohen PR
    Dermatol Online J; 2015 Aug; 21(8):. PubMed ID: 26437156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone Formation Parameters of the Biopsied Ilium Differ between Subtrochanteric and Diaphyseal Atypical Femoral Fractures in Bisphosphonate-Treated Patients.
    Kondo N; Fukuhara T; Watanabe Y; Miyasaka D; Yamamoto N; Sato H; Wada Y; Nakatsue T; Fujisawa J; Sakuma M; Imai N; Yoda T; Narita I; Endo N
    Tohoku J Exp Med; 2017 Dec; 243(4):247-254. PubMed ID: 29212985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of zoledronic acid in patients with breast cancer metastatic to bone: a multicenter clinical trial.
    Cartenì G; Bordonaro R; Giotta F; Lorusso V; Scalone S; Vinaccia V; Rondena R; Amadori D
    Oncologist; 2006; 11(7):841-8. PubMed ID: 16880243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bisphosphonate long-term treatment related bilateral subtrochanteric femoral fracture. Can teriparatide be useful?
    Tarazona-Santabalbina FJ; Aguilella-Fernández L
    Aging Clin Exp Res; 2013 Oct; 25(5):605-9. PubMed ID: 24026625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pelvic fractures associated with long-term bisphosphonate therapy - case report.
    Patel V; Graves L; Lukert B
    J Musculoskelet Neuronal Interact; 2013 Jun; 13(2):251-4. PubMed ID: 23728112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical femoral fracture in a beta-thalassemia major patient with previous bisphosphonate use: case report and a review of the literature.
    Lampropoulou-Adamidou K; Tournis S; Triantafyllopoulos IK
    J Musculoskelet Neuronal Interact; 2016 Mar; 16(1):75-8. PubMed ID: 26944826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of cancer-treatment-induced bone loss in postmenopausal women undergoing adjuvant breast cancer therapy: a Z-FAST update.
    Brufsky A
    Semin Oncol; 2006 Apr; 33(2 Suppl 7):S13-7. PubMed ID: 16730272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.